Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Data and Safety Monitoring Board evaluation and management of a renal adverse event signal in TOPCAT.

Bristow MR, Sharma K, Assmann SF, Linas S, Gersh BJ, Grady C, Rice MM, Singh S, Boineau R, McKinlay SM, Greenberg BH.

Eur J Heart Fail. 2017 Apr;19(4):457-465. doi: 10.1002/ejhf.686. Epub 2016 Nov 21.

2.

Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.

Pfeffer MA, Claggett B, Assmann SF, Boineau R, Anand IS, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Heitner JF, Lewis EF, O'Meara E, Rouleau JL, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, McKinlay SM, Pitt B.

Circulation. 2015 Jan 6;131(1):34-42. doi: 10.1161/CIRCULATIONAHA.114.013255. Epub 2014 Nov 18.

3.

Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.

Shah AM, Claggett B, Sweitzer NK, Shah SJ, Anand IS, O'Meara E, Desai AS, Heitner JF, Li G, Fang J, Rouleau J, Zile MR, Markov V, Ryabov V, Reis G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD.

Circ Heart Fail. 2014 Sep;7(5):740-51. doi: 10.1161/CIRCHEARTFAILURE.114.001583. Epub 2014 Aug 13.

4.

Spironolactone for heart failure with preserved ejection fraction.

Pfeffer MA, Pitt B, McKinlay SM.

N Engl J Med. 2014 Jul 10;371(2):181-2. doi: 10.1056/NEJMc1405715. No abstract available.

5.

Spironolactone for heart failure with preserved ejection fraction.

Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O'Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM; TOPCAT Investigators.

N Engl J Med. 2014 Apr 10;370(15):1383-92. doi: 10.1056/NEJMoa1313731.

6.

Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.

Shah AM, Shah SJ, Anand IS, Sweitzer NK, O'Meara E, Heitner JF, Sopko G, Li G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD; TOPCAT Investigators.

Circ Heart Fail. 2014 Jan;7(1):104-15. doi: 10.1161/CIRCHEARTFAILURE.113.000887. Epub 2013 Nov 18.

7.

IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.

Dampier CD, Smith WR, Wager CG, Kim HY, Bell MC, Miller ST, Weiner DL, Minniti CP, Krishnamurti L, Ataga KI, Eckman JR, Hsu LL, McClish D, McKinlay SM, Molokie R, Osunkwo I, Smith-Whitley K, Telen MJ; Sickle Cell Disease Clinical Research Network (SCDCRN).

Clin Trials. 2013 Apr;10(2):319-31. doi: 10.1177/1740774513475850.

8.

Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes.

Dampier CD, Smith WR, Kim HY, Wager CG, Bell MC, Minniti CP, Keefer J, Hsu L, Krishnamurti L, Mack AK, McClish D, McKinlay SM, Miller ST, Osunkwo I, Seaman P, Telen MJ, Weiner DL; Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).

Am J Hematol. 2011 Dec;86(12):E70-3. doi: 10.1002/ajh.22176. Epub 2011 Sep 22.

9.

The normal menopause transition.

McKinlay SM, Brambilla DJ, Posner JG.

Maturitas. 2008 Sep-Oct;61(1-2):4-16.

PMID:
19434875
10.

Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial.

Cooper HA, Domanski MJ, Rosenberg Y, Norman J, Scott JH, Assmann SF, McKinlay SM, Hochman JS, Antman EM; Magnesium in Coronaries trial investigators.

Am Heart J. 2004 Dec;148(6):1012-9.

PMID:
15632887
11.

Can follicle-stimulating hormone be used to define menopausal status?

Stellato RK, Crawford SL, McKinlay SM, Longcope C.

Endocr Pract. 1998 May-Jun;4(3):137-41.

PMID:
15251741
12.

A longitudinal study of weight and the menopause transition: results from the Massachusetts Women's Health Study.

Crawford SL, Casey VA, Avis NE, McKinlay SM.

Menopause. 2000 Mar-Apr;7(2):96-104.

PMID:
10746891
13.

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH.

N Engl J Med. 1999 Aug 26;341(9):625-34.

14.
15.

Psychosocial, behavioral, and health factors related to menopause symptomatology.

Avis NE, Crawford SL, McKinlay SM.

Womens Health. 1997 Summer;3(2):103-20.

PMID:
9332153
16.

Operational design and quality control in the CATCH multicenter Trial.

Stone EJ, Osganian SK, McKinlay SM, Wu MC, Webber LS, Luepker RV, Perry CL, Parcel GS, Elder JP.

Prev Med. 1996 Jul-Aug;25(4):384-99.

PMID:
8818063
17.

Batch sampling to improve power in a community trial. Experience from the Pawtucket Heart Health Program.

Feldman HA, McKinlay SM, Niknian M.

Eval Rev. 1996 Jun;20(3):244-74.

PMID:
10182204
18.

Outcomes of a field trial to improve children's dietary patterns and physical activity. The Child and Adolescent Trial for Cardiovascular Health. CATCH collaborative group.

Luepker RV, Perry CL, McKinlay SM, Nader PR, Parcel GS, Stone EJ, Webber LS, Elder JP, Feldman HA, Johnson CC, et al.

JAMA. 1996 Mar 13;275(10):768-76.

PMID:
8598593
19.

The normal menopause transition: an overview.

McKinlay SM.

Maturitas. 1996 Mar;23(2):137-45. Review.

PMID:
8735352
20.

Does collecting repeated blood samples from each subject improve the precision of estimated steroid hormone levels?

Brambilla DJ, McKinlay SM, McKinlay JB, Weiss SR, Johannes CB, Crawford SL, Longcope C.

J Clin Epidemiol. 1996 Mar;49(3):345-50.

PMID:
8676183

Supplemental Content

Loading ...
Support Center